It would be intricate and intriguing to investigate whether and how HER2 regulates NKX2-5 in wild-type and p53 mutant CRC and their subsequent effects on Wnt signaling and CRC invasives. The gene discussed is ERBB2; the disease is colorectal carcinoma.